Modified Range of Alanine Aminotransferase is Insufficient for Screening of Hepatitis C virus infection in Hemodialysis Patients (CROSBI ID 227355)
Prilog u časopisu | stručni rad
Podaci o odgovornosti
Milotić, Irena ; Pavić, Ivica ; Maleta, Ivica ; Trošelj-Vukić, Biserka ; Milotić, Franko
engleski
Modified Range of Alanine Aminotransferase is Insufficient for Screening of Hepatitis C virus infection in Hemodialysis Patients
Objective : A moderate increase in serum alanine aminotransferase (ALT) has been reported to be a helpful, low-cost tool for predicting viremia in anti-hepatitis C virus (HCV)-positive hemodialysis (HD) patients. This study focused on evaluating the effectiveness of a lowered normal serum ALT value as a screening method for HCV infection in HD patients. Material and Methods : Serum ALT levels were compared with HCV virologic status in 125 patients on maintenance HD. Results : The prevalence of HCV antibodies was 23%. A total of 3.7% of viremic HD patients did not have a detectable antibody response. Using the conventional upper limit of normal for ALT of 37 IU, there was no significant difference in the frequency of elevated ALT levels between HCV RNA-positive and -negative patients. However, if the upper limit of normal for ALT was lowered to 27 IU, the difference was significant. Nevertheless, 60% of viremic patients still fell within the normal range. Conclusion : Although inexpensive and widely available, the monitoring of serum ALT levels is not useful as a screening method for HCV infection in HD patients.
Alanine Aminotransferase ; Hepatitis C virus infection ; Hemodialysis
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
36 (6)
2002.
447-449
objavljeno
0036-5599
10.1080/003655902762467611
Povezanost rada
Kliničke medicinske znanosti